Skin boosters in Korea: Rejuran, Juvelook explained

Skin boosters like Rejuran and Juvelook are two of the treatments people ask about most when they book an aesthetic consultation in Korea. The honest framing is that they improve skin quality — hydration, texture, and firmness — rather than adding volume the way dermal fillers do. Rejuran is built around salmon-derived polynucleotides; Juvelook pairs PDLLA microparticles with hyaluronic acid. Both are approved in Korea by the Ministry of Food and Drug Safety (MFDS), and neither is FDA-approved as an injectable in the United States as of 2026. Here is what each one is, how they differ, and what their regulatory status means for you.

What are skin boosters, and how do they differ from fillers?#

A skin booster is an injectable treatment that deposits small amounts of a bioactive material into the skin to improve its overall quality, not to reshape or plump a specific area. That is the line that separates the category from the two treatments people confuse it with. Dermal fillers add volume mechanically by occupying space under the skin, and botulinum toxin relaxes the muscles that create expression lines. A skin booster does neither — it aims to nudge the skin itself toward better hydration, smoother texture, and firmer tone over a series of sessions.

Because the goal is skin quality rather than shape, the results build gradually and look subtle. You are not meant to see a new contour the day after; you are meant to see skin that reads smoother and more even over the following weeks. That difference in mechanism is worth holding onto when a clinic presents several options at once.

What is Rejuran, and what is it made of?#

Rejuran is a polynucleotide skin booster made by the Korean company PharmaResearch, and its active ingredient is a set of DNA fragments — polynucleotides (PN) and polydeoxyribonucleotide (PDRN) — extracted from salmon. Injected into the skin in a series of small deposits, these fragments are understood to signal the skin's repair machinery rather than to fill or plump. In practice, clinics use it to target hydration, fine texture, and elasticity.

The mechanism is biological, not mechanical. Polynucleotides are thought to support the fibroblasts that produce collagen, which is why the effect shows up as a gradual change in skin quality across weeks rather than an immediate result you can see leaving the clinic. Research on polynucleotides has grown over the past decade, though much of it is small in scale, so a measured tone about expected results is appropriate.

Rejuran is usually given as a course — commonly three or four sessions spaced a few weeks apart — followed by occasional maintenance. Because the product places material into reactive skin, temporary redness, swelling, small bumps at the injection points, and bruising are the effects most commonly reported. These typically settle within days, but they are the reason timing matters if you are travelling.

What is Juvelook, and how is it different from Rejuran?#

Juvelook is a hybrid skin booster made by the Korean company VAIM that combines PDLLA — poly-D,L-lactic acid — microparticles with non-crosslinked hyaluronic acid. The two components do different jobs: the hyaluronic acid gives an immediate hydration effect, while the PDLLA acts as a collagen biostimulator, prompting the skin to build new collagen gradually over the following months. That makes Juvelook a member of the same broad family as PLLA biostimulators used elsewhere, but with its own formulation and its own regulatory footprint.

The practical difference from Rejuran comes down to what is being stimulated and how. Rejuran works through salmon-derived polynucleotides that signal repair; Juvelook works through synthetic PDLLA microparticles that scaffold new collagen, paired with HA for an early plumping effect. Neither is a filler, but Juvelook's collagen-stimulating action overlaps conceptually with other firmness-focused approaches — if broader tightening is your goal, it is worth reading how energy-based skin tightening options work in Korea before deciding which route fits.

Like Rejuran, Juvelook is given as a course of sessions, and the possible effects include redness, swelling, bruising, and — because PDLLA is a particulate biostimulator — a small risk of firm bumps or nodules if the material clumps. A clinician's injection technique and dosing matter here, which is one reason the choice of clinic is not a detail.

Are Rejuran and Juvelook FDA-approved?#

As of 2026, neither Rejuran nor Juvelook is FDA-approved as an injectable in the United States. Both are approved in Korea by the MFDS, and Juvelook additionally carries a CE mark for Europe, but a product being approved in one country does not mean it is cleared in another. In the US, Rejuran-type polynucleotides have been available only in topical form rather than as an approved injectable, and Juvelook's PDLLA injectable is not FDA-cleared for aesthetic use there.

This does not mean nothing comparable exists in the US market — it means the specific products differ. In June 2023 the FDA approved Skinvive by Juvéderm, a hyaluronic acid microdroplet injectable, as the first product cleared in the US for improving skin smoothness of the cheeks rather than adding volume. Separately, PLLA biostimulators such as Sculptra are FDA-approved. The Korean-origin brands sit outside that approved set, which is exactly why medical travel is part of the conversation around them.

If you are weighing whether to have a course done during a trip, the regulatory gap is one more reason to choose your provider deliberately. Our guide to how to choose a dermatology clinic in Korea walks through credentials, communication, and aftercare — the same checks that protect you when a treatment is not one you could simply repeat at home.

What should you weigh before getting a skin booster in Korea?#

Start with expectations. Skin boosters are a managed, gradual treatment, not a one-time fix: results appear over weeks, they are subtle rather than dramatic, and they fade without maintenance. If you are hoping for an overnight transformation or a permanent change, the mismatch will lead to disappointment regardless of which product you choose.

Then think about candidacy and timing. Skin boosters suit people whose concern is skin quality across an area, and they are usually spaced over several visits — a pattern that rarely fits a short holiday. Because the days after an injection can involve redness, swelling, or small bumps, booking a session right before an important event or a packed sightseeing schedule is worth avoiding. Pregnancy, active skin infections, and certain medical conditions are common reasons a clinician will defer treatment, which is why an honest consultation comes first.

Finally, treat product transparency as non-negotiable. Ask which specific product and formulation is being used, whether it is MFDS-registered, how many sessions the clinician recommends and why, and what the aftercare and follow-up look like if you are leaving the country. A clinic that answers those questions clearly is giving you the information you need to decide; one that deflects is telling you something too.

✨ In short#

Skin boosters such as Rejuran and Juvelook are injectables that aim to improve skin quality rather than add volume, and they work through very different active ingredients — salmon polynucleotides for Rejuran, PDLLA plus hyaluronic acid for Juvelook. Both are approved in Korea by the MFDS but are not FDA-approved as injectables in the United States as of 2026, so where and by whom you receive them is part of the decision. Approach them as a gradual, maintained course, and choose the clinic as carefully as the product.